News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Burgess Paul D.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/07/2023 |
4
| Burgess Paul D. (See Remarks) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.
Txns:
| Bought 21,880 shares
@ $22.9339, valued at
$501.8k
|
|
07/06/2023 |
4
| Burgess Paul D. (See Remarks) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.
Txns:
| Granted 95,931 options to buy
@ $31.45, valued at
$3M
Granted 23,847 restricted stock units
@ $0 |
|
06/28/2023 |
3
| Burgess Paul D. (See Remarks) has filed a Form 3 on Cerevel Therapeutics Holdings, Inc. |
09/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/12/2019 |
4
| Burgess Paul D. (Chief Legal Officer) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Granted 150,000 options to buy
@ $7.95, valued at
$1.2M
|
|
06/27/2018 |
3
| Burgess Paul D. (General Counsel and Secretary) has filed a Form 3 on Translate Bio, Inc. |
|
|